Abstract
Summary
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
The global Flu Vaccine market is projected to reach US$ 7673.2 million by 2030 from an estimated US$ 5791.7 million in 2024, at a CAGR of 4.8% during 2024 and 2030.
Global Flu Vaccine key players include Sanofi Pasteur, CSL, GSK, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%. And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).
Report Scope
This report aims to provide a comprehensive presentation of the global market for Flu Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Flu Vaccine.
The Flu Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Flu Vaccine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Flu Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
Market Segmentation
By Company
Sanofi Pasteur
CSL
GSK
Mylan
Hulan Bio
AstraZeneca
CCBIO
Segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Segment by Application
For Children (6 months to 3 years)
For Adults and Children over 3 years
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Flu Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Flu Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Flu Vaccine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
The global Flu Vaccine market is projected to reach US$ 7673.2 million by 2030 from an estimated US$ 5791.7 million in 2024, at a CAGR of 4.8% during 2024 and 2030.
Global Flu Vaccine key players include Sanofi Pasteur, CSL, GSK, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%. And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).
Report Scope
This report aims to provide a comprehensive presentation of the global market for Flu Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Flu Vaccine.
The Flu Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Flu Vaccine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Flu Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
Market Segmentation
By Company
Sanofi Pasteur
CSL
GSK
Mylan
Hulan Bio
AstraZeneca
CCBIO
Segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Segment by Application
For Children (6 months to 3 years)
For Adults and Children over 3 years
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Flu Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Flu Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Flu Vaccine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Table of Contents
1 Study Coverage
1.1 Flu Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Flu Vaccine Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Market by Application
1.3.1 Global Flu Vaccine Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Flu Vaccine Market Size Estimates and Forecasts
2.1.1 Global Flu Vaccine Revenue 2019-2030
2.1.2 Global Flu Vaccine Sales 2019-2030
2.2 Flu Vaccine Market Size by Region: 2023 Versus 2030
2.3 Flu Vaccine Sales by Region (2019-2030)
2.3.1 Global Flu Vaccine Sales by Region: 2019-2024
2.3.2 Global Flu Vaccine Sales Forecast by Region (2025-2030)
2.3.3 Global Flu Vaccine Sales Market Share by Region (2019-2030)
2.4 Flu Vaccine Market Estimates and Projections by Region (2025-2030)
2.4.1 Global Flu Vaccine Revenue by Region: 2019-2024
2.4.2 Global Flu Vaccine Revenue Forecast by Region (2025-2030)
2.4.3 Global Flu Vaccine Revenue Market Share by Region (2019-2030)
3 Global Flu Vaccine by Manufacturers
3.1 Global Top Flu Vaccine Manufacturers by Sales
3.1.1 Global Flu Vaccine Sales by Manufacturer (2019-2024)
3.1.2 Global Flu Vaccine Sales Market Share by Manufacturer (2019-2024)
3.2 Global Top Flu Vaccine Manufacturers by Revenue
3.2.1 Global Flu Vaccine Revenue by Manufacturer (2019-2024)
3.2.2 Global Flu Vaccine Revenue Share by Manufacturer (2019-2024)
3.3 Global Flu Vaccine Price by Manufacturer (2019-2024)
3.4 Competitive Landscape
3.4.1 Key Flu Vaccine Manufacturers Covered: Ranking by Revenue
3.4.2 Global Flu Vaccine Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.4.3 Global Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Flu Vaccine Manufacturing Base Distribution, Product Type
3.5.1 Flu Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Flu Vaccine Product Type
3.5.3 Date of International Manufacturers Enter into Flu Vaccine Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Sanofi Pasteur
4.1.1 Sanofi Pasteur Company Information
4.1.2 Sanofi Pasteur Description, Business Overview
4.1.3 Sanofi Pasteur Flu Vaccine Products Offered
4.1.4 Sanofi Pasteur Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.1.5 Sanofi Pasteur Flu Vaccine Sales by Product in 2023
4.1.6 Sanofi Pasteur Flu Vaccine Sales by Application in 2023
4.1.7 Sanofi Pasteur Flu Vaccine Sales by Geographic Area in 2023
4.1.8 Sanofi Pasteur Recent Developments
4.2 CSL
4.2.1 CSL Company Information
4.2.2 CSL Description, Business Overview
4.2.3 CSL Flu Vaccine Products Offered
4.2.4 CSL Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.2.5 CSL Flu Vaccine Sales by Product in 2023
4.2.6 CSL Flu Vaccine Sales by Application in 2023
4.2.7 CSL Flu Vaccine Sales by Geographic Area in 2023
4.2.8 CSL Recent Developments
4.3 GSK
4.3.1 GSK Company Information
4.3.2 GSK Description, Business Overview
4.3.3 GSK Flu Vaccine Products Offered
4.3.4 GSK Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.3.5 GSK Flu Vaccine Sales by Product in 2023
4.3.6 GSK Flu Vaccine Sales by Application in 2023
4.3.7 GSK Flu Vaccine Sales by Geographic Area in 2023
4.3.8 GSK Recent Developments
4.4 Mylan
4.4.1 Mylan Company Information
4.4.2 Mylan Description, Business Overview
4.4.3 Mylan Flu Vaccine Products Offered
4.4.4 Mylan Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.4.5 Mylan Flu Vaccine Sales by Product in 2023
4.4.6 Mylan Flu Vaccine Sales by Application in 2023
4.4.7 Mylan Flu Vaccine Sales by Geographic Area in 2023
4.4.8 Mylan Recent Developments
4.5 Hulan Bio
4.5.1 Hulan Bio Company Information
4.5.2 Hulan Bio Description, Business Overview
4.5.3 Hulan Bio Flu Vaccine Products Offered
4.5.4 Hulan Bio Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.5.5 Hulan Bio Flu Vaccine Sales by Product in 2023
4.5.6 Hulan Bio Flu Vaccine Sales by Application in 2023
4.5.7 Hulan Bio Flu Vaccine Sales by Geographic Area in 2023
4.5.8 Hulan Bio Recent Developments
4.6 AstraZeneca
4.6.1 AstraZeneca Company Information
4.6.2 AstraZeneca Description, Business Overview
4.6.3 AstraZeneca Flu Vaccine Products Offered
4.6.4 AstraZeneca Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.6.5 AstraZeneca Flu Vaccine Sales by Product in 2023
4.6.6 AstraZeneca Flu Vaccine Sales by Application in 2023
4.6.7 AstraZeneca Flu Vaccine Sales by Geographic Area in 2023
4.6.8 AstraZeneca Recent Development
4.7 CCBIO
4.7.1 CCBIO Company Information
4.7.2 CCBIO Description, Business Overview
4.7.3 CCBIO Flu Vaccine Products Offered
4.7.4 CCBIO Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.7.5 CCBIO Flu Vaccine Sales by Product in 2023
4.7.6 CCBIO Flu Vaccine Sales by Application in 2023
4.7.7 CCBIO Flu Vaccine Sales by Geographic Area in 2023
4.7.8 CCBIO Recent Development
5 Breakdown Data by Type
5.1 Global Flu Vaccine Sales by Type (2019-2030)
5.1.1 Global Flu Vaccine Sales by Type (2019-2024)
5.1.2 Global Flu Vaccine Sales Forecast by Type (2025-2030)
5.1.3 Global Flu Vaccine Sales Market Share by Type (2019-2030)
5.2 Global Flu Vaccine Revenue Forecast by Type (2019-2030)
5.2.1 Global Flu Vaccine Revenue by Type (2019-2024)
5.2.2 Global Flu Vaccine Revenue Forecast by Type (2025-2030)
5.2.3 Global Flu Vaccine Revenue Market Share by Type (2019-2030)
5.3 Flu Vaccine Average Selling Price (ASP) by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Flu Vaccine Sales by Application (2019-2030)
6.1.1 Global Flu Vaccine Sales by Application (2019-2024)
6.1.2 Global Flu Vaccine Sales Forecast by Application (2025-2030)
6.1.3 Global Flu Vaccine Sales Market Share by Application (2019-2030)
6.2 Global Flu Vaccine Revenue Forecast by Application (2019-2030)
6.2.1 Global Flu Vaccine Revenue by Application (2019-2024)
6.2.2 Global Flu Vaccine Revenue Forecast by Application (2025-2030)
6.2.3 Global Flu Vaccine Revenue Market Share by Application (2019-2030)
6.3 Flu Vaccine Average Selling Price (ASP) by Application (2019-2030)
7 North America
7.1 North America Flu Vaccine Market Size YoY Growth 2019-2030
7.2 North America Flu Vaccine Market Facts & Figures by Country
7.2.1 North America Flu Vaccine Sales by Country (2019-2030)
7.2.2 North America Flu Vaccine Revenue by Country (2019-2030)
7.3 North America Flu Vaccine Sales by Type (2019-2024)
7.4 North America Flu Vaccine Sales by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Flu Vaccine Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Flu Vaccine Market Facts & Figures by Region
8.2.1 Asia-Pacific Flu Vaccine Sales by Region (2019-2030)
8.2.2 Asia-Pacific Flu Vaccine Revenue by Region (2019-2030)
8.3 Asia-Pacific Flu Vaccine Sales by Type (2019-2024)
8.4 Asia-Pacific Flu Vaccine Sales by Application (2019-2024)
9 Europe
9.1 Europe Flu Vaccine Market Size YoY Growth 2019-2030
9.2 Europe Flu Vaccine Market Facts & Figures by Country
9.2.1 Europe Flu Vaccine Sales by Country (2019-2030)
9.2.2 Europe Flu Vaccine Revenue by Country (2019-2030)
9.3 Europe Flu Vaccine Sales by Type (2019-2024)
9.4 Europe Flu Vaccine Sales by Application (2019-2024)
10 Latin America
10.1 Latin America Flu Vaccine Market Size YoY Growth 2019-2030
10.2 Latin America Flu Vaccine Market Facts & Figures by Country
10.2.1 Latin America Flu Vaccine Sales by Country (2019-2030)
10.2.2 Latin America Flu Vaccine Revenue by Country (2019-2030)
10.3 Latin America Flu Vaccine Sales by Type (2019-2024)
10.4 Latin America Flu Vaccine Sales by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Flu Vaccine Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Flu Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Flu Vaccine Sales by Country (2019-2030)
11.2.2 Middle East and Africa Flu Vaccine Revenue by Country (2019-2030)
11.3 Middle East and Africa Flu Vaccine Sales by Type (2019-2024)
11.4 Middle East and Africa Flu Vaccine Sales by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Flu Vaccine Supply Chain Analysis
12.2 Flu Vaccine Key Raw Materials and Upstream Suppliers
12.3 Flu Vaccine Clients Analysis
12.4 Flu Vaccine Sales Channel and Sales Model Analysis
12.4.1 Flu Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Flu Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Flu Vaccine Distributors
13 Market Dynamics
13.1 Flu Vaccine Industry Trends
13.2 Flu Vaccine Market Drivers
13.3 Flu Vaccine Market Challenges
13.4 Flu Vaccine Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer